News & Articles

Collaborative research effort reduces off-target CRISPR-Cas9 genome editing, removing barriers for human therapeutic applications

Study aims for early detection of pancreatic cancer using blood-based IMMray PanCan-d test

A celebration of the clinical laboratory products that have made the most difference to your lab work, plus we reveal our most popular clinical interviews of the past year

AACC 2018 plenary speaker, Professor James Collins, provides an insight into the future of synthetic biology and CRISPR-based diagnostic tools

SelectScience will be attending the AACC Annual Meeting in Chicago, USA, to interview leading scientists and report on the latest technologies

How scientists at Birmingham Women’s and Children’s Hospital have integrated the latest advancements in clinical mass spectrometry to provide better treatment for serious metabolic disorders

Presentation at ECCMID 2018 shows equal or better detection over comparable tests

Improved diagnostics will help characterize risk in patients undergoing colorectal cancer chemotherapy

University of Missouri School of Medicine pilots Roche’s cloud-based NAVIFY Tumor Board solution to streamline & standardize data collection and presentation, enabling faster, better collaboration among oncology care teams

To be in with a chance of winning a $500 Amazon voucher, cast your vote by July 23

Researchers investigate faulty versions of a gene called titin, carried by one in 100 people

Which new product, instrument or consumable has made the most difference to your clinical lab or point-of-care practice? Nominate now for a chance to win a $500/£400/450€ Amazon voucher

The personal genomics product will focus on 59 genes identified by the American College of Medical Genetics and Genomics

AACR and CRUK, two of the biggest cancer research committees around the globe to join force to aid the development of cancer therapeutics

The AACR and the UBS oncology impact fund aim to use the new funding gift program to propel breakthroughs in cancer research and therapeutics

Metafora biosystems receives exceptional reimbursement for the new METAglut1 test to help diagnose De Vivo disease

New Synapsys microbiology informatics solution will be demonstrated at the event

NYU school of medicine becomes the most recent cancer center to join PanFAM-1 prospective study